4//SEC Filing
Lea Darrell Shane 4
Accession 0001140361-22-045712
CIK 0001279704other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 5:00 PM ET
Size
5.2 KB
Accession
0001140361-22-045712
Insider Transaction Report
Form 4
Lea Darrell Shane
Chief Commercial Officer
Transactions
- Award
Stock option (right to buy)
2022-11-21+100,000→ 100,000 totalExercise: $1.90Exp: 2032-11-21→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option shall vest in three equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continuous employment by the Issuer on each vesting date.
Documents
Issuer
Cellectar Biosciences, Inc.
CIK 0001279704
Entity typeother
Related Parties
1- filerCIK 0001958526
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 5:00 PM ET
- Size
- 5.2 KB